Impact of allele-specific anti-HLA class I antibodies on organ allocation.

[1]  T. Ecder,et al.  Correlation of Luminex-Based Single Antigen Based Results With Complement-Dependent Cytotoxicity Crossmatch and Flow Cytometry Crossmatch Results: A Single-Center Experience From Istanbul. , 2023, Transplantation proceedings.

[2]  K. Osoegawa,et al.  A new strategy for systematically classifying HLA alleles into serological specificities , 2022, HLA.

[3]  T. Muthukumar,et al.  Principles of Virtual Crossmatch Testing for Kidney Transplantation , 2022, Kidney international reports.

[4]  A. Norin,et al.  Antibodies to cryptic epitopes on HLA class I and class II heavy chains bound to single antigen beads: Clinically relevant? , 2021, Transplant immunology.

[5]  G. P. Morris,et al.  Incidence and impact of allele-specific anti-HLA antibodies and high-resolution HLA genotyping on assessing immunologic compatibility. , 2021, Human immunology.

[6]  A. Pande,et al.  Comparative analysis of complement-dependent lymphocytotoxicity crossmatch and flow cytometry crossmatch results versus Luminex single-antigen bead-based donor-specific IgG class I antibody MFI values in live related renal transplant cases; a retrospective observation in 102 cases , 2020, Journal of immunoassay & immunochemistry.

[7]  A. A. Nielsen,et al.  Organ donation in the US and Europe: The supply vs demand imbalance. , 2020, Transplantation reviews.

[8]  J. Kobashigawa,et al.  Stem cell donor HLA typing improves CPRA in kidney allocation , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  D. Keith.  Parsing the 100% calculated panel reactive antibody kidney transplant candidates: Who gets transplanted? , 2020, HLA.

[10]  D. Segev,et al.  The national landscape of deceased donor kidney transplantation for the highly sensitized: Transplant rates, waitlist mortality, and posttransplant survival under KAS , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[11]  R. Bray,et al.  The Road to HLA Antibody Evaluation: Do Not Rely on MFI , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  P. Terasaki,et al.  Conformational Variants of the Individual HLA-I Antigens on Luminex Single Antigen Beads Used in Monitoring HLA Antibodies: Problems and Solutions , 2017, Transplantation.

[13]  Joshua Pyke,et al.  Allocating Deceased Donor Kidneys to Candidates with High Panel-Reactive Antibodies. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[14]  J. Moreau,et al.  Evaluation of the iBeads assay as a tool for identifying class I HLA antibodies. , 2015, Human immunology.

[15]  E. Milford,et al.  P038 : USE OF HLA-ALLELE PAIRS WHICH DIFFER ONLY IN BW4/BW6 FOR ANTIBODY ANALYSIS , 2014 .

[16]  P S Heeger,et al.  Comprehensive Assessment and Standardization of Solid Phase Multiplex‐Bead Arrays for the Detection of Antibodies to HLA , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[17]  Christopher P. Johnson,et al.  Diagnostic accuracy of solid phase HLA antibody assays for prediction of crossmatch strength. , 2012, Human immunology.

[18]  W. Bodmer,et al.  Nomenclature for factors of the HLA system, 2010 , 2010, Tissue antigens.

[19]  Jeffrey T. Sholander,et al.  Using real data for a virtual crossmatch. , 2009, Human immunology.

[20]  J. Friedewald,et al.  Perception Versus Reality?: Virtual Crossmatch—How to Overcome Some of the Technical and Logistic Limitations , 2009 .

[21]  R. Bray,et al.  Donor-reactive HLA antibodies in renal allograft recipients: considerations, complications, and conundrums. , 2009, Human immunology.

[22]  V. D’Agati,et al.  Sensitivity, specificity and clinical relevance of different cross-matching assays in deceased-donor renal transplantation. , 2008, Transplant immunology.

[23]  M Setterholm,et al.  The HLA Dictionary 2004: a summary of HLA‐A, ‐B, ‐C, ‐DRB1/3/4/5 and ‐DQB1 alleles and their association with serologically defined HLA‐A, ‐B, ‐C, ‐DR and ‐DQ antigens , 2005, International journal of immunogenetics.

[24]  R. Redfield,et al.  Kidney transplantation of highly sensitized recipients under the new kidney allocation system: A reflection from five different transplant centers across the United States. , 2017, Human immunology.

[25]  A. Jackson.  The Virtual Crossmatch: An Essential Tool for Transplanting Sensitized Patients. , 2014, Clinical transplants.